- am still keeping an eye on FLC. Maybe,just maybe ....
Fluence repositions strategy to focus on Membrane Activated Biofilm Reactor and Smart Products Solutions, changes MD & CEO, and reaffirms guidance
Summary
1. Strategic repositioning is designed to focus primarily on three (3) key segments:
.... MABR wastewater solutions in China and Southeast Asia;
.... NIROBOX TM desalination solutions in the Middle East and Southeast Asia; and
.... the Ivory Coast water treatment project
2. Continued development of strategic channel distribution partners and further improvement of operational efficiencies
3. Effective immediately, Richard Irving, Chairman, will also assume the role of CEO, replacing Henry Charrabé
2020 guidance reaffirmed
• EBITDA positive for the full year (excluding any one-time costs)
• US$32 million in SPS sales
• US$9 million in recurring revenue
(fortune favours the brave. Missed the recent run; don't HOLD)